Connection
Sapna Patel to Vaccines, Subunit
This is a "connection" page, showing publications Sapna Patel has written about Vaccines, Subunit.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.676 |
|
|
|
-
Patel SP, Petroni GR, Roszik J, Olson WC, Wages NA, Chianese-Bullock KA, Smolkin M, Varhegyi N, Gaughan E, Smith KT, Haden K, Hall EH, Gnjatic S, Hwu P, Slingluff CL. Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma. J Immunother Cancer. 2021 08; 9(8).
Score: 0.676